Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-08 4:39 pm Purchase | 2023-12-06 | 13D | Cazoo Group Ltd CZOOF | Farallon Capital Partners, L.P. | 714,240 14.600% | 704,240 (+7042.40%) | Filing History |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners, L.P. | 6,762,480 6.200% | 6,762,480 (New Position) | Filing History |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 3,961,602 7.100% | 3,961,602 (New Position) | Filing History |
| 2023-11-07 5:04 pm Unchanged | 2023-11-03 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.500% | 0 (Unchanged) | Filing History |
| 2023-10-16 4:45 pm Purchase | 2023-10-04 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 15,381,069 5.900% | 383,065 (+2.55%) | Filing History |
| 2023-09-22 5:05 pm Unchanged | 2023-09-20 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.500% | 0 (Unchanged) | Filing History |
| 2023-09-22 3:20 pm Purchase | 2023-09-13 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 4,113,469 5.200% | 713,548 (+20.99%) | Filing History |
| 2023-08-11 5:17 pm Purchase | 2023-08-02 | 13D | Chinook Therapeutics, Inc. KDNY | Farallon Capital Partners, L.P. | 7,110,000 9.900% | 7,110,000 (New Position) | Filing History |
| 2023-08-10 3:57 pm Purchase | 2023-07-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 151,505 9.900% | 151,505 (New Position) | Filing History |
| 2023-06-16 5:21 pm Unchanged | 2023-06-15 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-06-02 4:59 pm Purchase | 2023-05-31 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 25,860,000 7.900% | 2,394,000 (+10.20%) | Filing History |
| 2023-05-16 5:25 pm Unchanged | 2023-05-12 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-04-27 5:28 pm Unchanged | 2023-04-25 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-04-06 8:54 pm Unchanged | 2023-04-05 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 23,466,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-04-06 4:58 pm Purchase | 2023-03-29 | 13G | Forest Road Acquisition Corp. II FRXB | Farallon Capital Partners, L.P. | 400,000 8.900% | 400,000 (New Position) | Filing History |
| 2023-03-27 4:33 pm Unchanged | 2023-03-23 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 23,466,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-03-24 1:34 pm Purchase | 2023-03-17 | 13D | Cazoo Group Ltd CZOO | Farallon Capital Partners, L.P. | 10,000 2.500% | 10,000 (New Position) | Filing History |
| 2023-03-20 4:39 pm Purchase | 2023-03-09 | 13D | Exelixis, Inc. EXEL | Farallon Capital Partners, L.P. | 23,466,000 7.200% | 23,466,000 (New Position) | Filing History |
| 2023-02-17 3:20 pm Purchase | 2023-02-08 | 13G | AVROBIO, Inc. AVRO | Farallon Capital Partners, L.P. | 259,667 7.100% | 259,667 (New Position) | Filing History |
| 2023-02-14 08:27 am Sale | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 3,399,921 4.800% | -151,850 (-4.28%) | Filing History |